Brief: Recro Pharma Reports Q3 Loss Per Share $0.07
09/11/2021 22:47
Nov 9 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.07
* SEES FY REVENUE $74 MILLION TO $76 MILLION
* Q3 REVENUE $18.2 MILLION
Source text for Eikon: ID:nGNXcvqcf
Further company coverage: REPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview